Skip to content
10-Q

Quarterly Report

AV THERAPEUTICS, INC.

0001185185-14-002260

← back to feed
Filed
Aug 19, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 15, 2014 81.88M sh
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$626.17K
Operating Cash Flow restated Q2 2014 · Jun 30, 2013 −$180.45K
Cash And Equivalents Q2 2014 · Jun 30, 2014 $471.08K
Cash And Equivalents Q2 2014 · Dec 31, 2013 $576.25K
Cash And Equivalents restated Q2 2014 · Jun 30, 2013 $91.99K
Cash And Equivalents restated Q2 2014 · Dec 31, 2012 $97.44K
Stockholders Equity Q2 2014 · Jun 30, 2014 −$602.63K
Stockholders Equity Q2 2014 · Dec 31, 2013 $34.17K
Current Liabilities Q2 2014 · Jun 30, 2014 $1.24M
Current Liabilities Q2 2014 · Dec 31, 2013 $750.76K
Current Assets Q2 2014 · Jun 30, 2014 $501.83K
Current Assets Q2 2014 · Dec 31, 2013 $636.25K
Total Assets Q2 2014 · Jun 30, 2014 $640.21K
Total Assets Q2 2014 · Dec 31, 2013 $784.93K
Sga Expense Q2 2014 · Jun 30, 2014 $69.1K
Sga Expense Q2 2014 · Jun 30, 2014 $121K
Sga Expense Q2 2014 · Jun 30, 2013 $18.34K
Sga Expense Q2 2014 · Jun 30, 2013 $29.11K
Rd Expense Q2 2014 · Jun 30, 2014 $179.08K
Rd Expense Q2 2014 · Jun 30, 2014 $294.33K
Rd Expense Q2 2014 · Jun 30, 2013 $33.3K
Rd Expense Q2 2014 · Jun 30, 2013 $60.3K
Net Income Q2 2014 · Jun 30, 2014 $92.37K
Net Income Q2 2014 · Jun 30, 2014 −$308.51K
Net Income Q2 2014 · Jun 30, 2014 −$308.51K
Net Income restated Q2 2014 · Jun 30, 2013 −$71.81K
Net Income restated Q2 2014 · Jun 30, 2013 −$173.62K
Operating Income Q2 2014 · Jun 30, 2014 −$569.5K
Operating Income Q2 2014 · Jun 30, 2014 −$970.38K
Operating Income Q2 2014 · Jun 30, 2013 −$71.61K
Operating Income Q2 2014 · Jun 30, 2013 −$173.09K
Revenue Q2 2014 · Jun 30, 2014 $0
Revenue Q2 2014 · Jun 30, 2014 $0
Revenue Q2 2014 · Jun 30, 2013 $0
Revenue Q2 2014 · Jun 30, 2013 $0
Stock Issued Q2 2014 · Jun 30, 2013 1.17M sh